dr. wakelee discusses adjuvant therapy in elderly nsclc patients
Published 12 years ago • 209 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
1:26
dr. wakelee on explaining adjuvant therapy benefits to patients
-
1:05
dr. wakelee discusses adjuvant therapy predictive markers
-
0:59
dr. weksler on neoadjuvant and adjuvant therapy in nsclc
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
1:23
dr. wakelee discusses current state of treatment in nsclc
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
1:40
dr. wakelee on immediate therapy options in lung cancer
-
7:30
the use of adjuvant therapy in elderly patients with resected non-small cell lung cancer (nsclc)
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
5:41
prescribing adjuvant chemotherapy in elderly patients
-
1:21
dr. wakelee on importance of ngs testing in nsclc
-
1:33
dr. wakelee on continued maintenance in lung cancer
-
1:55
dr. heather wakelee discusses nintedanib plus chemotherapy in nsclc
-
1:29
dr. wakelee on available treatments following tumor progression in lung cancer
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc